Arizona State Retirement System decreased its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 0.1% during the 4th quarter, HoldingsChannel.com reports. The firm owned 223,332 shares of the company’s stock after selling 146 shares during the period. Arizona State Retirement System’s holdings in Colgate-Palmolive were worth $20,303,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of CL. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter valued at $32,000. Bernard Wealth Management Corp. bought a new stake in Colgate-Palmolive during the fourth quarter valued at $36,000. Finally, Roxbury Financial LLC bought a new stake in Colgate-Palmolive during the fourth quarter valued at $43,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Trading Up 0.9 %
CL opened at $91.87 on Thursday. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The firm has a market capitalization of $74.56 billion, a PE ratio of 26.10, a P/E/G ratio of 4.20 and a beta of 0.44. The company’s 50-day moving average is $88.72 and its 200 day moving average is $95.27.
Colgate-Palmolive Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date was Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.
Analyst Upgrades and Downgrades
A number of analysts have commented on CL shares. Piper Sandler cut their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research report on Monday, January 6th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. Morgan Stanley cut their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Wells Fargo & Company cut their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Raymond James reissued an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Tickers Leading a Meme Stock Revival
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Market Cap Calculator: How to Calculate Market Cap
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.